Amiko provides Respiro, a digital medicine platform for use with connected inhalers that combines data, AI, and elegant digital experiences to upgrade respiratory care.

2018年2月5日 · At the core of the platform: Respiro Sense, the technology that powers the world’s most advanced inhaler sensors. Combined with inhalers for asthma, COPD and CF, the sensors automatically capture data on the patient’s inhalation profiles to monitor when and how well patients use their medication.

2019年5月6日 · The system delivered consistent improvements in treatment use and outcomes: 37% increase in controller medication adherence, 42% improvement in optimal inhaler technique, and a 67% reduction in rescue medication use.

2018年10月1日 · Respiro, a digital medicine offering that uses advanced smart inhalers, AI and software to measure and improve respiratory therapies, will be integrated into the everyday practice of doctor’s offices in Germany as part of the KBV Future Practice (KBV-Zukunfstpraxis) innovation project.

2018年7月3日 · Luz Saúde will integrate Amiko’s Respiro platform into asthma and COPD care, enabling nurses to optimise respiratory treatments and support patients to self-care, to improve outcomes and lower healthcare costs.

2020年12月7日 · The RS01X™ is integrated with Amiko’s Respiro, a digital medicine platform for use with connected inhalers that combines data, artificial intelligence (AI), and elegant digital experiences to upgrade respiratory care.

2017年12月8日 · Respiro includes medication sensors that collect unique inhalation data, to help monitor compliance, lung function and disease progression. The sensors are bundled with a mobile application, which receives this data and offers simple metrics and personalized support for improved disease control.

2022年1月15日 · Amiko receives CE mark for use of the Respiro Platform with Teva’s Spiromax® Inhaler, Chiesi’s Nexthaler® inhaler and GlaxoSmithKline’s Ellipta® inhaler London,

2018年2月13日 · Amiko’s Respiro platform, which has recently received the CE mark for use with certain inhaler systems, enables real-time monitoring of medication use and patient health. The patented Respiro Sense sensors, which are attached …

2018年9月25日 · Amiko’s first product is Respiro, a digital medicine offering that optimises respiratory therapies using the world’s most advanced smart inhalers. Respiro has been used in clinical studies and over 20 commercial programs in …